School of Medicine

Showing 1-6 of 6 Results

  • Mobeen Rahman

    Mobeen Rahman

    Clinical Associate Professor, Pathology

    BioI have interest in head and neck oncological surgical pathology. Specifically in salivary gland, thyroid, and skull base related malignancies.

    Prior to joining faculty as an assistant professor at Stanford University, I completed a head and neck surgical pathology fellowship at the MD Anderson Cancer Center (2019). Following this subspecialty fellowship, I was faculty as a head and neck only pathologist at Cleveland Clinic for three years.

  • . Muthukumar Ramanathan

    . Muthukumar Ramanathan

    Instructor, Pathology

    • Other Names:
      Ramanathan
  • Donald Regula, MD

    Donald Regula, MD

    Professor (Teaching) of Pathology, Emeritus

    BioDr. Regula was the course director for the required medical student course, Science of Medicine, and previously the course director of the required pathology course (1993-2020)
    He was the Director of the Stanford Autopsy Service (1995-2021)
    He is the faculty co-lead for the EPIC Beaker-AP implementation project.

  • Mara Rendi

    Mara Rendi

    Adjunct Clinical Professor, Pathology

  • Kerri E. Rieger, MD, PhD

    Kerri E. Rieger, MD, PhD

    Clinical Professor, Pathology
    Clinical Professor, Dermatology

    BioDr. Rieger is a Clinical Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in cutaneous lymphoma, hospitalized patients, and patients with autoimmune disease. She also sees patients in the Stanford dermatology clinic in Portola Valley, where her clinical interest is adult general dermatology.

  • Theodore Roth

    Theodore Roth

    Instructor, Pathology

    Current Research and Scholarly InterestsThe Roth Lab develops, applies, and translates scalable genetic manipulation technologies in primary human cells and complex in vivo tissue environments. Working with students, trainees, and staff with backgrounds across bioengineering, genetics, immunology, oncology, and pathology, the lab has developed CRISPR-All, a unified genetic perturbation language able to arbitrarily and combinatorially examine genetic perturbations across perturbation type and scale in primary human cells. Ongoing applications of CRISPR-All in the lab have revealed surprising capacities to synthetically engineer human cells beyond evolved cellular states. These new capacities to perturb human cell’s genetics beyond their evolved functionality drives ongoing work to understand the biology and therapeutic potential of synthetic cell state engineering - in essence learning how to build new human genes tailor made for a specific cell and specific environment to drive previously inaccessible therapeutic cellular functions.

    • Contact Info
      Mail Code: 5324
    • Other Names:
      Theo Roth